Kyrle disease associated with hidradenitis suppurativa successfully treated with tumor necrosis factor inhibition.

Clicks: 345
ID: 95640
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #10 of 18 articles by views in journal of the european academy of dermatology and venereology : jeadv

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A 41-year-old woman with a diagnosis of Kyrle disease (KD) and multitherapy-resistant hidradenitis suppurativa (HS) was referred for evaluation after having been unsuccessfully treated with oral retinoids (isotretinoin 0.5 mg/Kg/die for 6 months), and several cycles of antibiotics (clindamycin, rifampin, tetracycline). She had KD and HS since the age of 38 and 35 years, respectively, was a heavy tobacco smoker (20 cigarettes daily), and had a medical history of acne and rheumatoid arthritis (Charlson Comorbidity Index, CCI, score 0). An eventual familiarity for HS was not referred. The clinical examination showed numerous hyperpigmented, itchy, follicular keratotic papulo-nodular lesions on her upper and lower limbs related to the KD.
Reference Key
babino2020kyrlejournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Babino, G;Fulgione, E;Russo, T;Agozzino, M;D'Ambra, I;Giorgio, C M;Alfano, R;Argenziano, G;
Journal journal of the european academy of dermatology and venereology : jeadv
Year 2020
DOI
10.1111/jdv.16296
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.